Sciensano hosts the National Reference Centre (NRC) which provides epidemiological monitoring for the bacteria Neisseria meningitidis (meningococcus) and Listeria monocytogenes (listeria). The Belgian Official Medicines Control Laboratory (OMCL) of Sciensano, together with the European OMCL network, is responsible for the quality control of the meningitis vaccine prior to marketing.
